27 November 2023 Calym
RedTalks #3 Saison 4: Towards Risk-Adapted a...
06 November 2023 Calym
RedTalks #2 Saison 4: IDH2 mutation in T-Cel...
16 October 2023 Calym
RedTalks #1 Saison 4: Novel insight into the...
04 July 2023 Calym
Launch of the 1st edition of the OncoSTART Su...
29 June 2023 Calym
CALYM is proud to present the new version of ...
06 June 2023 Calym
OncoSTART Summit & PhDMeeting Oncology J...
21 December 2022 Calym
The CeVi CAR-T collection, which gathers samp...
14 December 2022 Calym
CALYM and Embleema sign a strategic partnersh...
02 December 2022 Calym
Congratulations to the 2 new winners of the C...
18 October 2022 Calym
The CALYM call for projects: an investment of...
24 June 2022 Calym
Euranova and the Carnot CALYM Institute combi...
Private Research and Development (R&D) center Euranova, specialized in data...
03 June 2022 Calym
Follow-up on the CALYM Janssen 2022 meeting
02 June 2022 Calym
Rise of the Artificial Intelligence program o...
The Artificial Intelligence program of the Carnot Institute CALYM has been ...
24 March 2022 Calym
CALYM members at the SFH
29 December 2021 Calym
CALYM: strong dynamics engaged with FINDMED
08 December 2021 Calym
AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING...
01 December 2021 Calym
A STRUCTURING INTEGRATING THE ENTIRE VALUE CH...
29 November 2021 Calym
Congratulations to the 2 new winners of the C...
24 November 2021 Calym
ANTICANCER CELL THERAPY GROUP AND INSTITUT CA...
02 November 2021 Calym
ISSUES IN LYMPHOMA RESEARCH
22 October 2021 Calym
14th edition of the Rendez-vous Carnot
11 October 2021 Calym
CALYM’s active role in the research eco...
03 October 2021 Calym
With OncoSTARTUPPER, participate in the Oncol...
31 May 2021 Calym
Launch of OncoSTART consortium supporting onc...